chemie.pr-stock-channel.net - Das Finanzportal - Preterax(R) Prevents and ...
Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics.Benutzername Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics
Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics
16.06.2008 17:40:11
Servier Laboratories: Berlin (ots/PRNewswire) - New results of the ADVANCE (Action in Diabetes and Vascular disease: PreterAx and DiamicroN-MR Controlled Evaluation) trial have been presented today at the European Society of Hypertension (ESH) and show that the antihypertensive Preterax - a fixed combination of the ACE-inhibitor perindopril and the diuretic indapamide - reduces the likelihood of new or worsening nephropathy (kidney damage) in patients ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- First Study in Real-Life Setting Confirms That Once-Monthly Mircera Keeps Haemoglobin Levels Within a Tight Range
- Alzheimer's Disease International (ADI)(1) Launches Worldwide Campaign to Address Growing Public Health and Social Care Emergency
- New Data Confirms Avastin (R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
- UNICEF and Pampers Announce Partnership Aimed at Eliminating Deadly Disease by 2012
- MabThera Maintenance Therapy Helps Non-Hodgkin's Lymphoma Patients Live for Years Longer Without Their Disease Progressing
- Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
- Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
- MIRCERA Keeps Haemoglobin Levels Stable With Significantly Fewer Dose Changes Than With Other ESAs
- Fenofibrate Reduces the Risk of Amputations in Patients With Type 2 Diabetes
- First Glycoengineered, Humanized, Type II CD20 Monoclonal Antibody to Enter Clinical Trials Could Offer Hope for Difficult to Treat Lymphoma Patients
Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics ...
Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics.Servier Laboratories: Berlin (ots/PRNewswire) - New results of the ADVANCE (Action in Diabetes
News zu Wirtschaft, Politik, Finanzen, Gesundheit und Gold
Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics the ADVANCE (Action in Diabetes and Vascular disease: PreterAx and DiamicroN-MR
ots.at: das APA-OTS-Portal für multimediale Presseaussendungen
ots.at: das APA-OTS-Portal für multimediale Presseaussendungen. Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics = 16.06.2008 / 16:53
Presseportal: Servier Laboratories
Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics the ADVANCE (Action in Diabetes and Vascular disease: PreterAx and DiamicroN-MR